Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $13.4 million.

  • Kezar Life Sciences' Total Current Liabilities fell 3452.45% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year decrease of 3452.45%. This contributed to the annual value of $20.3 million for FY2024, which is 1456.83% up from last year.
  • Kezar Life Sciences' Total Current Liabilities amounted to $13.4 million in Q3 2025, which was down 3452.45% from $14.4 million recorded in Q2 2025.
  • Kezar Life Sciences' Total Current Liabilities' 5-year high stood at $20.4 million during Q3 2024, with a 5-year trough of $5.9 million in Q2 2021.
  • Its 5-year average for Total Current Liabilities is $12.9 million, with a median of $13.6 million in 2023.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 9552.88% in 2023, then crashed by 3452.45% in 2025.
  • Quarter analysis of 5 years shows Kezar Life Sciences' Total Current Liabilities stood at $8.2 million in 2021, then surged by 33.91% to $11.0 million in 2022, then soared by 61.35% to $17.7 million in 2023, then increased by 14.57% to $20.3 million in 2024, then tumbled by 34.2% to $13.4 million in 2025.
  • Its Total Current Liabilities stands at $13.4 million for Q3 2025, versus $14.4 million for Q2 2025 and $17.0 million for Q1 2025.